Prognosis
Homegrown Indian Covid Vaccine Already in Use Shows 78% Efficacy
- Bharat Biotech vaccine shows 100% efficacy versus severe Covid
- Indian medical agency says vaccine works against most variants
This article is for subscribers only.
An Indian Covid-19 shot showed 78% efficacy from interim data at preventing mild, moderate and severe reactions to the disease and worked against most variants of the virus as the South Asian nation struggles to contain a record surge across the country.
The inoculation known as Covaxin, a two-shot injection that uses an inactivated or dead form the virus, also showed 100% efficacy at preventing severe symptoms and hospitalizations against the coronavirus, vaccine maker Bharat Biotech International Ltd. and the Indian Council for Medical Research, the co-developers, said in a joint statement on Wednesday.